Studies have shown that in hepatocellular carcinoma, down-regulation of UCK2 induces cell cycle arrest and activates the age-related secretory phenotype associated with the TNF-α NFκB signaling pathway to alter the tumor microenvironment. Here, UCK2 is linked to hepatocellular carcinoma.